Two pioneering digital therapeutics (DTx) for addiction are available once again after their original developer Pear Therapeutics was dissolved last year. The two FDA-approved apps – RESET and ...

“Sandoz believes that Pear is now well-suited to continue to bring these important digital therapeutics to patients, [healthcare professionals] and payers,” it continues. A separate ...

WiSA Technologies, Inc. , soon to be doing business as Datavault® AI, is introducing a fusion of its DVHolo holographic display and ADIO® technologies at New York Fashion Week (NYFW) through its ...

The stock price for Pear Therapeutics Inc Class A (OTC: PEARQ) is $0.000001 last updated May 22, 2024 at 9:30 AM EDT. Q Does Pear Therapeutics Inc Class A (PEARQ) pay a dividend?

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

“My topical treatment pearl is ruxolitinib 1.5% cream b.i.d ... one of the authors of a recent consensus statement on the use of topical therapeutics for vitiligo in children, adolescents ...

Apple CEO Tim Cook said Apple Intelligence helped drive record iPhone upgrades over the holiday quarter.

DelveInsight’s c-MET-NSCLC pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline therapies for c-MET-NSCLC treatment. The leading c-MET-NSCLC Companies such as ...

AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases, today announced the appointment of Matthew Hawryluk, Ph.D., MBA, as Chief ...

Initial public offerings from oil-and-gas company Infinity Natural Resources Inc. and medical-device maker Beta Bionics Inc. both rose in their stock markets debut Friday, as they brushed aside losses ...